Next Article in Journal
NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2′,2′-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer
Next Article in Special Issue
Potential Inherent Stimulation of the Innate Immune System by Nucleic Acid Aptamers and Possible Corrective Approaches
Previous Article in Journal
Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing

1
College of Marine Life and Fisheries, Huahai Institute of Technology, Lianyungang 222005, China
2
Marine Resources Development Institute of Jiangsu, Lianyungang 222005, China
3
Co-Innovation Center of Jiangsu Marine Bio-industry Technology, Huaihai Institute of Technology, Lianyungang 222005, China
4
Verschuren Centre for Sustainability in Energy & the Environment, Cape Breton University, Sydney, NS B1P 6L2, Canada
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2018, 11(2), 35; https://doi.org/10.3390/ph11020035
Submission received: 8 March 2018 / Revised: 10 April 2018 / Accepted: 10 April 2018 / Published: 21 April 2018
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)

Abstract

Enhancing the limit of detection (LOD) is significant for crucial diseases. Cancer development could take more than 10 years, from one mutant cell to a visible tumor. Early diagnosis facilitates more effective treatment and leads to higher survival rate for cancer patients. Rolling circle amplification (RCA) is a simple and efficient isothermal enzymatic process that utilizes nuclease to generate long single stranded DNA (ssDNA) or RNA. The functional nucleic acid unit (aptamer, DNAzyme) could be replicated hundreds of times in a short period, and a lower LOD could be achieved if those units are combined with an enzymatic reaction, Surface Plasmon Resonance, electrochemical, or fluorescence detection, and other different kinds of biosensor. Multifarious RCA-based platforms have been developed to detect a variety of targets including DNA, RNA, SNP, proteins, pathogens, cytokines, micromolecules, and diseased cells. In this review, improvements in using the RCA technique for medical biosensors and biomedical applications were summarized and future trends in related research fields described.
Keywords: rolling circle amplification (RCA); biosensor; clinical diagnostics; cancer rolling circle amplification (RCA); biosensor; clinical diagnostics; cancer

Share and Cite

MDPI and ACS Style

Gu, L.; Yan, W.; Liu, L.; Wang, S.; Zhang, X.; Lyu, M. Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing. Pharmaceuticals 2018, 11, 35. https://doi.org/10.3390/ph11020035

AMA Style

Gu L, Yan W, Liu L, Wang S, Zhang X, Lyu M. Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing. Pharmaceuticals. 2018; 11(2):35. https://doi.org/10.3390/ph11020035

Chicago/Turabian Style

Gu, Lide, Wanli Yan, Le Liu, Shujun Wang, Xu Zhang, and Mingsheng Lyu. 2018. "Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing" Pharmaceuticals 11, no. 2: 35. https://doi.org/10.3390/ph11020035

APA Style

Gu, L., Yan, W., Liu, L., Wang, S., Zhang, X., & Lyu, M. (2018). Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing. Pharmaceuticals, 11(2), 35. https://doi.org/10.3390/ph11020035

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop